ofloxacin has been researched along with Primary Peritonitis in 40 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred twenty-three cirrhotics with uncomplicated spontaneous bacterial peritonitis (no septic shock, grade II-IV hepatic encephalopathy, serum creatinine level of > 3 mg/dL, and gastrointestinal hemorrhage or ileus) were randomly given oral ofloxacin (64 patients) or intravenous cefotaxime (59 patients)." | 9.08 | Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. ( Arroyo, V; Bañares, R; Castells, L; Clemente, G; Follo, A; Forné, M; Guarner, C; Jimenez De Anta, MT; Llovet, JM; Marco, F; Navasa, M; Planas, R; Rimola, A; Rodés, J; Vargas, V, 1996) |
| "This prospective randomized study is an evaluation of efficacy of cefazolin and ofloxacin in 23 end-stage renal disease (ESRD) patients treated with continuous ambulatory peritoneal dialysis (CAPD) who experienced 38 episodes of peritonitis (P)." | 9.07 | Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients? ( Bren, AF; Gucek, A; Hergouth, V; Lindic, J; Mlinsek, D, 1994) |
| "Forty six patients who developed 48 episodes of peritonitis while on CAPD were randomised to receive either oral ofloxacin or intraperitoneal (i." | 9.07 | A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). ( Chan, CY; Cheng, IK; Wong, WT, 1991) |
| " Hypoglycemia because of use of levofloxacin is a rarely reported complication." | 7.74 | Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. ( Abraham, J; Jacob, JJ; Kapoor, R; Singh, M, 2008) |
| "Thirty cirrhotic patients with spontaneous bacterial peritonitis were assigned to receive either intravenous (1 g/12 h) cefotaxime for 7 days (n=17) or intravenous (200 mg/12 h) ofloxacin for 2 days followed by oral (200 mg/12 h) ofloxacin for 5 days (n=13)." | 7.72 | Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis. ( Aslan, SL; Buyraç, Z; Colakoğlu, O; Sözmen, B; Taşkiran, B; Unsal, B, 2004) |
| "Seven patients with end-stage renal disease requiring support by continuous ambulatory peritoneal dialysis received once-daily 400 mg oral ofloxacin for 7 days for the treatment of bacterial peritonitis." | 7.69 | The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis. ( Brown, IM; Brown, NM; MacGown, AP; McMullin, CM; Reeves, DS; Tomson, CR; White, LO, 1997) |
| "Eighteen episodes of peritonitis in 16 CAPD patients were treated with oral ofloxacin 400 mg initially, followed by 300 mg daily for a total of 10 days." | 7.67 | Oral treatment of peritonitis in CAPD patients with ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "Two open studies of oral treatment of peritonitis in CAPD patients with ofloxacin are described." | 7.67 | Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "One hundred twenty-three cirrhotics with uncomplicated spontaneous bacterial peritonitis (no septic shock, grade II-IV hepatic encephalopathy, serum creatinine level of > 3 mg/dL, and gastrointestinal hemorrhage or ileus) were randomly given oral ofloxacin (64 patients) or intravenous cefotaxime (59 patients)." | 5.08 | Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. ( Arroyo, V; Bañares, R; Castells, L; Clemente, G; Follo, A; Forné, M; Guarner, C; Jimenez De Anta, MT; Llovet, JM; Marco, F; Navasa, M; Planas, R; Rimola, A; Rodés, J; Vargas, V, 1996) |
| "This prospective randomized study is an evaluation of efficacy of cefazolin and ofloxacin in 23 end-stage renal disease (ESRD) patients treated with continuous ambulatory peritoneal dialysis (CAPD) who experienced 38 episodes of peritonitis (P)." | 5.07 | Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients? ( Bren, AF; Gucek, A; Hergouth, V; Lindic, J; Mlinsek, D, 1994) |
| "Forty six patients who developed 48 episodes of peritonitis while on CAPD were randomised to receive either oral ofloxacin or intraperitoneal (i." | 5.07 | A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). ( Chan, CY; Cheng, IK; Wong, WT, 1991) |
| "Among several regimes used in the oral treatment of continuous ambulatory peritoneal dialysis (CAPD)--related peritonitis, ciprofloxacin and ofloxacin showed the higher treatment efficacy, with an overall cure rate of 80% over a treatment duration of 10-16 days." | 4.81 | The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis. ( Oreopoulos, D; Passadakis, P, 2001) |
| " Renal-dose levofloxacin was utilized as part of an antimicrobial regimen to treat post-operative peritonitis." | 3.74 | Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia. ( Gregory, J; Huesmann, G; Jakoby, MG; Vallurupalli, S, 2008) |
| " Hypoglycemia because of use of levofloxacin is a rarely reported complication." | 3.74 | Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. ( Abraham, J; Jacob, JJ; Kapoor, R; Singh, M, 2008) |
| "Thirty cirrhotic patients with spontaneous bacterial peritonitis were assigned to receive either intravenous (1 g/12 h) cefotaxime for 7 days (n=17) or intravenous (200 mg/12 h) ofloxacin for 2 days followed by oral (200 mg/12 h) ofloxacin for 5 days (n=13)." | 3.72 | Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis. ( Aslan, SL; Buyraç, Z; Colakoğlu, O; Sözmen, B; Taşkiran, B; Unsal, B, 2004) |
| "Seven patients with end-stage renal disease requiring support by continuous ambulatory peritoneal dialysis received once-daily 400 mg oral ofloxacin for 7 days for the treatment of bacterial peritonitis." | 3.69 | The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis. ( Brown, IM; Brown, NM; MacGown, AP; McMullin, CM; Reeves, DS; Tomson, CR; White, LO, 1997) |
| "Eighteen episodes of peritonitis in 16 CAPD patients were treated with oral ofloxacin 400 mg initially, followed by 300 mg daily for a total of 10 days." | 3.67 | Oral treatment of peritonitis in CAPD patients with ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "Two open studies of oral treatment of peritonitis in CAPD patients with ofloxacin are described." | 3.67 | Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin. ( Chan, MK; Chan, WW; Chau, PY, 1988) |
| "Levofloxacin seems to be a good alternative treatment for patients with uncomplicated spontaneous ascites infections." | 1.36 | A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. ( Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T, 2010) |
| "Cryoglobulinemia has been described in infectious diseases, but in only three patients with brucellosis." | 1.33 | Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis. ( Hermida Lazcano, I; Sáez Méndez, L; Solera Santos, J, 2005) |
| "The optimal period of antibiotic treatment of hepatic failure with SBP should be from 7 days to 10 days." | 1.32 | [A prospective study on short period antibiotic treatment of hepatic failure complicated with spontaneous bacterial peritonitis]. ( Du, N; He, WP; Ji, W; Li, HW; Wang, HF; Xia, J; Zhao, P, 2004) |
| "Ofloxacin was measured using high-pressure liquid chromatography (HPLC) in the serum and peritoneal effluent over 24 hours." | 1.29 | Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis. ( Chan, CY; Chau, PY; Cheng, IK; Kou, M; Kumana, CR; Siu, LK, 1993) |
| " every 6 h for one day only, while 4 patients with acute peritonitis were treated with this same dosage every 4 h for 3 days, then every 6 h for the next 7 days." | 1.28 | Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients. ( Borner, K; Conrad, W; Hain, H; Kampf, D, 1991) |
| "7 hours after administration and the mean elimination half-life of OFX was 25 hours." | 1.27 | Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. ( Chan, MK; Chan, WW; Chau, PY, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.50) | 18.7374 |
| 1990's | 20 (50.00) | 18.2507 |
| 2000's | 14 (35.00) | 29.6817 |
| 2010's | 3 (7.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vallurupalli, S | 1 |
| Huesmann, G | 1 |
| Gregory, J | 1 |
| Jakoby, MG | 1 |
| Yakar, T | 1 |
| Güçlü, M | 1 |
| Serin, E | 1 |
| Alişkan, H | 1 |
| Husamettin, E | 1 |
| Monescillo Francia, A | 1 |
| Mohan, P | 1 |
| Venkataraman, J | 1 |
| Shi, G | 1 |
| Chen, X | 1 |
| Wang, H | 1 |
| Wang, S | 1 |
| Guo, X | 1 |
| Zhang, X | 1 |
| Alberti, LE | 1 |
| Lopez-Gomez, A | 1 |
| Alberti-Flor, JJ | 1 |
| Taşkiran, B | 1 |
| Colakoğlu, O | 1 |
| Sözmen, B | 1 |
| Unsal, B | 1 |
| Aslan, SL | 1 |
| Buyraç, Z | 1 |
| Li, HW | 1 |
| Zhao, P | 1 |
| Wang, HF | 1 |
| Ji, W | 1 |
| He, WP | 1 |
| Du, N | 1 |
| Xia, J | 1 |
| Hermida Lazcano, I | 1 |
| Sáez Méndez, L | 1 |
| Solera Santos, J | 1 |
| Guettrot-Imbert, G | 1 |
| Letranchant, L | 1 |
| Gallot, D | 1 |
| Romaszko, C | 1 |
| Laurichesse, H | 1 |
| Esposito, S | 1 |
| Noviello, S | 1 |
| Leone, S | 1 |
| Ianniello, F | 1 |
| Ascione, T | 1 |
| Gaeta, GB | 1 |
| Shinagawa, N | 1 |
| Yura, J | 1 |
| Takeyama, H | 1 |
| Taniguchi, M | 1 |
| Mikamo, H | 1 |
| Tamaya, T | 1 |
| Ito, K | 1 |
| Izumi, K | 1 |
| Tanaka, K | 1 |
| Watanabe, K | 1 |
| Singh, M | 1 |
| Jacob, JJ | 1 |
| Kapoor, R | 1 |
| Abraham, J | 1 |
| Cormican, MG | 1 |
| Runyon, BA | 1 |
| Jones, RN | 1 |
| Battista, C | 1 |
| Kane, MP | 1 |
| Moon, DG | 1 |
| Bailie, GR | 1 |
| Gucek, A | 1 |
| Bren, AF | 1 |
| Lindic, J | 1 |
| Hergouth, V | 1 |
| Mlinsek, D | 1 |
| Flament-Saillour, M | 1 |
| de Truchis, P | 1 |
| Risbourg, M | 1 |
| Nordmann, P | 1 |
| Barretti, P | 1 |
| Bignardi, JH | 1 |
| Soares, VA | 1 |
| Sesso, R | 1 |
| Parisio, K | 1 |
| Dalboni, A | 1 |
| Rabelo, T | 1 |
| Barbosa, D | 1 |
| Cendoroglo, M | 1 |
| Pignatari, A | 1 |
| Draibe, S | 1 |
| Ajzen, H | 1 |
| Cheng, IK | 3 |
| Chau, PY | 4 |
| Kumana, CR | 1 |
| Chan, CY | 2 |
| Kou, M | 1 |
| Siu, LK | 1 |
| Riley, UB | 1 |
| Bignardi, G | 1 |
| Goldberg, L | 1 |
| Johnson, AP | 1 |
| Holmes, B | 1 |
| Navasa, M | 1 |
| Follo, A | 1 |
| Llovet, JM | 1 |
| Clemente, G | 1 |
| Vargas, V | 1 |
| Rimola, A | 1 |
| Marco, F | 1 |
| Guarner, C | 1 |
| Forné, M | 1 |
| Planas, R | 1 |
| Bañares, R | 1 |
| Castells, L | 1 |
| Jimenez De Anta, MT | 1 |
| Arroyo, V | 1 |
| Rodés, J | 1 |
| García-Tsao, G | 1 |
| McMullin, CM | 1 |
| Brown, NM | 1 |
| Brown, IM | 1 |
| Tomson, CR | 1 |
| White, LO | 1 |
| Reeves, DS | 1 |
| MacGown, AP | 1 |
| Winkeltau, GJ | 1 |
| Töns, C | 1 |
| Bertram, P | 1 |
| Schumpelick, V | 1 |
| Vychytil, A | 2 |
| Lorenz, M | 1 |
| Schneider, B | 1 |
| Hörl, WH | 2 |
| Haag-Weber, M | 1 |
| Konner, P | 1 |
| Watschinger, B | 1 |
| Apfalter, P | 1 |
| Passadakis, P | 1 |
| Oreopoulos, D | 1 |
| Soares-Weiser, K | 1 |
| Paul, M | 1 |
| Brezis, M | 1 |
| Leibovici, L | 1 |
| Dan, M | 1 |
| Gutman, R | 1 |
| Biro, A | 1 |
| Kampf, D | 1 |
| Borner, K | 1 |
| Hain, H | 1 |
| Conrad, W | 1 |
| Wong, WT | 1 |
| Janknegt, R | 1 |
| Pagniez, DC | 1 |
| Vrtovsnik, F | 1 |
| Delvallez, L | 1 |
| Reade, R | 1 |
| Dequiedt, P | 1 |
| Tacquet, A | 1 |
| Chan, MK | 4 |
| Ng, WS | 1 |
| Chan, WW | 3 |
3 reviews available for ofloxacin and Primary Peritonitis
| Article | Year |
|---|---|
The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Oflo | 2001 |
Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Evidence-Based Medicine; Female; Gram-Negative Bac | 2002 |
CAPD peritonitis and fluoroquinolones: a review.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Pefloxacin; Peritoneal Dialysis, Continuous | 1991 |
7 trials available for ofloxacin and Primary Peritonitis
| Article | Year |
|---|---|
[Effectiveness of switch therapy for peritonitis].
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Administr | 2007 |
Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
Topics: Adult; Aged; Cefazolin; Female; Humans; Male; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuou | 1994 |
Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Administration, Topical; Adult; Catheters, Indwelling; Female; Fusidic Acid; H | 1994 |
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; C | 1996 |
New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography.
Topics: Abdominal Abscess; Adult; Aged; Bacterial Infections; Catheters, Indwelling; Female; Follow-Up Studi | 1998 |
A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Topics: Administration, Oral; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans; Ofloxacin; | 1991 |
A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacteria; Cephalothin; Drug Therapy, Combination | 1990 |
30 other studies available for ofloxacin and Primary Peritonitis
| Article | Year |
|---|---|
Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia.
Topics: Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Hypoglycemia; Kidne | 2008 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime | 2010 |
[Spontaneous bacterial peritonitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Humans; Ofloxacin; Peritonitis; Primary Prevention | 2009 |
Prevalence and risk factors for unsuspected spontaneous ascitic fluid infection in cirrhotics undergoing therapeutic paracentesis in an outpatient clinic.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefotaxime; Drug Therapy, Combina | 2011 |
Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Chromatography, High Pressure Liquid; Dise | 2012 |
Spontaneous bacterial peritonitis in a patient with myxedema ascites.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ascites; Female; Humans; Hypothyroidism; Klebsiella | 2003 |
Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.
Topics: Adult; Aged; Analysis of Variance; Cefotaxime; Dose-Response Relationship, Drug; Drug Administration | 2004 |
[A prospective study on short period antibiotic treatment of hepatic failure complicated with spontaneous bacterial peritonitis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; | 2004 |
Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Brucella melitensis; Brucellosis; Cryoglobulinemia; Doxycyclin | 2005 |
[Multiorgan failure due to gonococcal peritonitis in an HIV-HCV co-infected female patient].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ascites; Bacteremia; Carcinoma, Hepatocellular | 2004 |
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study.
Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Tolerance; Female; Humans; Levofl | 2006 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgica | 2006 |
Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Fatal O | 2008 |
In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Aerobic; Ceftizoxime; Enterobacteriaceae; Hu | 1995 |
Stability of ofloxacin in peritoneal dialysis solutions.
Topics: Bacterial Infections; Chromatography, High Pressure Liquid; Dialysis Solutions; Drug Stability; Huma | 1995 |
Yersinia enterocolitica peritonitis in a patient infected with the human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Humans; Male; Ofloxacin; Peritonitis; Yersinia enteroc | 1994 |
Successful treatment of peritonitis in IPD with oral fluoroquinolone.
Topics: Administration, Oral; Ciprofloxacin; Humans; Ofloxacin; Peritoneal Dialysis; Peritoneal Dialysis, Co | 1994 |
Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.
Topics: Aged; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Ofloxacin; Peritoneal | 1993 |
Quinolone resistance in Oligella urethralis-associated chronic ambulatory peritoneal dialysis peritonitis.
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Huma | 1996 |
Treatment of spontaneous bacterial peritonitis with oral ofloxacin: inpatient or outpatient therapy?
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Humans; Ofloxacin; Peritonitis | 1996 |
The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Aged; Anti-Infective Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ofloxa | 1997 |
[Stage-oriented antibiotic therapy of peritonitis. Prospective study].
Topics: Anti-Infective Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Combined Modality Therapy; | 1997 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; | 1999 |
A case of continuous ambulatory peritoneal dialysis peritonitis with an uncommon organism and an atypical clinical course.
Topics: C-Reactive Protein; Dialysis Solutions; Equipment Failure; Graft Rejection; Humans; Kidney Transplan | 2001 |
Peritonitis caused by Pseudomonas putrefaciens in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: Aged; Female; Gentamicins; Humans; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuous Ambulator | 1992 |
Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients.
Topics: Acute Disease; Aged; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; | 1991 |
Ofloxacin treatment may mask tuberculous peritonitis in CAPD patients.
Topics: Aged; Aged, 80 and over; Humans; Male; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Perito | 1991 |
Oral treatment of peritonitis in CAPD patients with ofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Administration Schedule; Female; Humans; Male; M | 1988 |
Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Humans; Ofloxacin; Perito | 1988 |
Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
Topics: Adult; Anti-Infective Agents; Ascitic Fluid; Creatinine; Female; Humans; Male; Middle Aged; Ofloxaci | 1987 |